购物车
- 全部删除
- 您的购物车当前为空
Mavacamten (MYK-461) 是一种可口服的心肌肌球蛋白 ATP 酶抑制剂,在牛心脏和人心脏中的IC50值分别为 490和711 nM。
Mavacamten (MYK-461) 是一种可口服的心肌肌球蛋白 ATP 酶抑制剂,在牛心脏和人心脏中的IC50值分别为 490和711 nM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 289 | 现货 | |
2 mg | ¥ 362 | 现货 | |
5 mg | ¥ 496 | 现货 | |
10 mg | ¥ 795 | 现货 | |
25 mg | ¥ 1,590 | 现货 | |
50 mg | ¥ 2,430 | 现货 | |
100 mg | ¥ 3,690 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 546 | 现货 |
产品描述 | Mavacamten (MYK-461) is an orally bioavailable inhibitor of cardiac myosin ATPase,( IC50s of 490, 711 nM for bovine cardiac and human cardiac, respectively) |
靶点活性 | ATPase (human cardiac myosin):711 nM, ATPase (Bovine cardiac myosin):490 nM |
体外活性 | MYK-461的研究显示,在牛体系中具有490 nM的IC50值,在人体系中为711 nM,在兔体系中为2140 nM,表明其对心脏肌球蛋白的选择性大于四倍[1]。 |
体内活性 | MYK-461 降低心脏收缩力,防止左心室肥大,并逆转病理性重塑。在猫中,它缓解左心室流出道阻塞[2]。 |
动物实验 | Five?cats received a combination of alfaxalone and midazolam for anesthetic induction, followed by inhaled isoflurane and oxygen maintenance.?Blood pressure was measured via an automated blood pressure cuff at five-minute intervals with supplementary continuous monitoring by arterial line when arterial access could be obtained.?Following induction of anesthesia, a complete baseline echocardiogram was performed (timepoint #1).?Cats were then treated with atropine 0.04 mg/kg IV, followed by an infusion of isoproterenol 0.04 μg/kg/min IV to elevate heart rate back to pre-anesthetized values and induce the previously observed LVOT obstruction.?After five to seven minutes, a stable heart rate of 200–220 bpm was reached and a complete echocardiogram was performed (timepoint #2).?At the completion of imaging, a ten-minute intravenous infusion of MYK-461 (n = 5) at 0.3 mg/kg/hr IV was started.?Focused echocardiography was performed after five minutes (timepoint #3).?After ten minutes, the MYK-461 infusion rate was lowered to 0.12 mg/kg/hr IV, a blood sample was drawn and an echocardiogram performed (timepoint #4).?If ventricular function remained hypercontractile or within normal limits by visual inspection, another blood sample was obtained and the MYK-461infusion rate was increased to 0.36 mg/kg/hr IV for ten minutes.?Focused echocardiography was performed after five minutes (timepoint #5).?After ten minutes, the MYK-461 infusion rate was lowered to 0.15 mg/kg/hr IV, a blood sample was drawn and an echocardiogram performed (timepoint #6).?Following imaging, the isoproterenol infusion was discontinued.?When heart rate returned to baseline levels (five to seven minutes), a complete echocardiogram was performed on MYK-461 alone (timepoint #7).?Study drug was then discontinued, and animals were awakened, extubated and moved to recovery.?Three of five cats were available to return for a control arm of this experiment after a 6-week washout period.The experiment was completed with identical methodology with the exception that MYK-461 was substituted for vehicle (control) at matched volumes/infusion rates[2]. |
别名 | SAR439152, MYK-461 |
分子量 | 273.33 |
分子式 | C15H19N3O2 |
CAS No. | 1642288-47-8 |
Smiles | CC(C)n1c(=O)cc(N[C@@H](C)c2ccccc2)[nH]c1=O |
密度 | 1.19 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 150 mg/mL (548.79 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容